Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

151.13 +0.08 (+0.05%)
Official Closing Price Updated: 7:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,052,610
Open 151.18
Bid (Size) 151.13 (20)
Ask (Size) 152.00 (1)
Prev. Close 151.05
Today's Range 150.11 - 151.69
52wk Range 150.11 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Have $1,000? 2 Smart Stocks to Buy This Month
The market is still giving investors great opportunities to buy exceptional companies. 
Via The Motley Fool
3 Safe Dow Dividend Stocks to Buy Now
These companies combine regimented growth with income for a balanced overall value. 
Via The Motley Fool

Performance

YTD
-15.19%
-15.19%
1 Month
-4.35%
-4.35%
3 Month
-14.63%
-14.63%
6 Month
-9.06%
-9.06%
1 Year
-13.31%
-13.31%

More News

Read More
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
Think the Bear Market Is Over? Here's How to Invest $5,000
Via The Motley Fool
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via TheNewswire.com
Exposures Product Safety
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via News Direct
Exposures Product Safety
Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy
Via The Motley Fool
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
2 Stocks That Should Be Better Buys After Their Spinoffs This Year
Via The Motley Fool
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Via Benzinga
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
Via The Motley Fool
Top 8 Stocks To Profit From Rising Interest Rates
Via Talk Markets
3 Retirement Investing Moves to Help Get You Back on Track
Via The Motley Fool
Johnson & Johnson Unusual Options Activity
Via Benzinga
Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study
Via Benzinga
5 Stocks You Can Confidently Invest $500 in Right Now
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
Via Investor's Business Daily
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
Via Benzinga
7 Blue-Chip Stocks to Buy and Hold for Decades
Via InvestorPlace
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
3 Blue-Chip Dividend Stocks to Buy on the Dip Now
Via InvestorPlace
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
5 Forever Dividend Stocks
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.